Vertex Pharmaceuticals Archives - Page 2 of 2 - Inside Precision Medicine

Inside Precision Medicine One and Done? How CRISPR Is Changing the Clinical Outlook for Multiple Diseases

Angled DNA Double Helix

News & Features

One and Done? How CRISPR Is Changing the Clinical Outlook for Multiple Diseases

Laura Cowen

June 5, 2023

Using the Epigenome to Guide Development of Gene Edited Therapies

News & Features

Using the Epigenome to Guide Development of Gene Edited Therapies

Helen Albert

May 31, 2023

Blood clot made of red blood cells, platelets and fibrin protein strands. Thrombus

News & Features

Bluebird Tightens Sickle Cell Race with BLA for Gene Therapy

April 25, 2023

Vertex Taps Mammoth’s CRISPR Tech in Gene Therapy Deal Worth up to $695M

News & Features

Vertex Taps Mammoth’s CRISPR Tech in Gene Therapy Deal Worth up to $695M

October 26, 2021

Genetic engineering, GMO and Gene manipulation concept. Hand is inserting sequence of DNA. 3D illustration of DNA.

News & Features

Vertex Sweetens Deal with CRISPR Therapeutics by $900M for Blood Disorders Gene Therapy Candidate

April 20, 2021

12Page 2 of 2

Related Content

New Research Highlights How DNA Circles Drive Cancer Growth and Drug Resistance

New Research Highlights How DNA Circles Drive Cancer Growth and Drug Resistance

The End of the Beginning for Cell and Gene Therapy, Part 2

The End of the Beginning for Cell and Gene Therapy, Part 2

International Working Group Publishes Revised Diagnostic Criteria for Alzheimer's Disease

International Working Group Publishes Revised Diagnostic Criteria for Alzheimer's Disease

Behind the Breakthroughs: How to Turn $1,000,000 CAR Ts into “Real” Medicines

Behind the Breakthroughs: How to Turn $1,000,000 CAR Ts into “Real” Medicines